KMT5B and squamous cell carcinoma: The high prevalence of gain/amplification of SUV420H1 was also observed in other squamous carcinomas, including lung and bladder SCC, supporting that SUV420H1 may function as a pan-squamous epigenetic driver (Supplementary Fig. 1).